GDR MD Medical Group Inv. PLC Financial Statements (MDMG) |
||||||||||
Мать и Дитя (MD)smart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 12.09.2023 | 30.10.2023 | 01.04.2024 | 26.04.2024 | 29.08.2024 | 29.08.2024 | ||||
Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
Financial report URL | ||||||||||
Presentation URL | ||||||||||
Revenue, bln rub | ? | 6.63 | 6.79 | 7.99 | 7.66 | 8.10 | 30.5 | |||
Operating Income, bln rub | 3.27 | 4.24 | 4.10 | 8.34 | ||||||
EBITDA, bln rub | ? | 4.10 | 5.12 | 5.12 | ||||||
Net profit, bln rub | ? | 3.37 | 4.45 | 4.89 | 9.34 | |||||
Net profit not adj., bln rub | ? | 3.37 | ||||||||
OCF, bln rub | ? | 4.37 | 5.01 | 5.22 | 10.2 | |||||
CAPEX, bln rub | ? | 1.95 | 1.63 | 0.512 | 0.950 | 3.09 | ||||
FCF, bln rub | ? | 2.51 | 3.49 | 5.20 | 8.69 | |||||
Dividend payout, bln rub | 10.6 | 1.70 | 12.3 | |||||||
Dividend, rub/share | ? | 141 | 22 | 163 | ||||||
Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 14.2% | 2.6% | 18.5% | ||||
Dividend payout ratio, % | 0% | 0% | 35% | 132% | ||||||
OPEX, bln rub | 1.69 | 2.08 | 2.18 | 4.26 | ||||||
Cost of production, bln rub | 7.89 | 8.45 | 9.46 | 17.9 | ||||||
Assets, bln rub | 36.4 | 41.3 | 46.4 | 46.4 | ||||||
Net Assets, bln rub | ? | 30.2 | 34.6 | 28.6 | 28.6 | |||||
Debt, bln rub | 0.640 | 0.876 | 0.000 | 1.28 | 1.28 | |||||
Cash, bln rub | 6.65 | 9.89 | 10.9 | 14.6 | 14.6 | |||||
Net debt, bln rub | -6.01 | 0.00 | -9.02 | -10.9 | -13.3 | -13.3 | ||||
Ordinary share price, rub | 632.6 | 842.8 | 775.3 | 990.0 | 831.7 | 883.0 | ||||
Number of ordinary shares, mln | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | ||||
Market cap, bln rub | 47.5 | 63.3 | 58.2 | 74.4 | 62.5 | 66.3 | ||||
EV, bln rub | ? | 41.5 | 63.3 | 49.2 | 63.4 | 49.2 | 53.0 | |||
Book value, bln rub | 28.2 | 0.00 | 32.4 | 0.00 | 26.4 | 26.4 | ||||
EPS, rub | ? | 44.9 | 0.00 | 59.3 | 0.00 | 65.1 | 124.4 | |||
FCF/share, rub | 33.4 | 0.00 | 46.5 | 0.00 | 69.2 | 115.7 | ||||
BV/share, rub | 375.9 | 0.00 | 430.9 | 0.00 | 351.3 | 351.3 | ||||
EBITDA margin, % | ? | 61.8% | 0.0% | 64.1% | 0.0% | 0.0% | 16.8% | |||
Net margin, % | ? | 50.8% | 0.0% | 55.8% | 0.0% | 60.4% | 30.6% | |||
FCF yield, % | ? | 14.0% | 10.5% | 10.3% | 8.1% | 13.9% | 13.1% | |||
ROE, % | ? | 23.1% | 22.6% | 32.7% | 32.7% | |||||
ROA, % | ? | 19.2% | 18.9% | 20.1% | 20.1% | |||||
P/E | ? | 6.81 | 9.07 | 7.45 | 9.51 | 6.69 | 7.10 | |||
P/FCF | 18.9 | 9.71 | 12.4 | 7.19 | 7.63 | |||||
P/S | ? | 1.83 | 2.41 | 2.11 | 2.56 | 2.05 | 2.17 | |||
P/BV | ? | 1.68 | 1.80 | 2.37 | 2.51 | |||||
EV/EBITDA | ? | 4.90 | 7.48 | 5.34 | 6.88 | 9.60 | 10.4 | |||
Debt/EBITDA | -0.71 | 0.00 | -0.98 | -1.19 | -2.60 | -2.60 | ||||
Employees, people | 8 413 | 8 805 | ||||||||
Labour productivity, mln rub/person/year | 0.79 | 0.91 | ||||||||
Expenses per employee, thousand rub | 0.00 | 0.00 | ||||||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
CAPEX/Revenue, % | 29% | 0% | 20% | 7% | 12% | 10% | ||||
GDR MD Medical Group Inv. PLC shareholders |